Methods and devices for occlusion of an atrial appendage

Abstract

Some embodiments of the invention provide a system for occluding a left atrial appendage of a patient. Some embodiments of the system can include a ring occluder that can be positioned around the left atrial appendage and a ring applicator to position the ring occluder with respect to the left atrial appendage. One embodiment discloses a method of accessing endocardial surfaces of the heart through the atrial appendage. Additional embodiments of the invention provide a clip occluder that can be positioned around the left atrial appendage. A clip applicator can position the clip occluder with respect to the left atrial appendage.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application is a continuation of U.S. application Ser. No. 11 / 788,261, filed Apr. 19, 2007, which is a continuation-in-part of U.S. application Ser. No. 11 / 155,699, filed Jun. 17, 2005, which claims the benefit of U.S. Application Ser. Nos. 60 / 581,223, filed on Jun. 18, 2004, and 60 / 685,681, filed on May 27, 2005, all of which are incorporated herein by reference in their entirety. This application also claims the benefit of U.S. Application Ser. No. 60 / 795,752 filed Apr. 28, 2006, the disclosure of which is also incorporated herein by reference in its entirety.FIELD OF THE INVENTION[0002]The invention relates to methods and devices for occlusion or ligation of an atrial appendage.BACKGROUND OF THE INVENTION[0003]Embolic stroke is the nation's third leading killer for adults. Embolic stroke is also a major cause of disability. The most common cause of embolic stroke is thrombus formation in the left appendage on the atrium. In almost...

AI Technical Summary

Benefits of technology

"The invention provides a system for occluding a left atrial appendage of a patient. The system includes a ring occluder and a ring applicator to position the ring occluder with respect to the left atrial appendage. The ring applicator can include a ring spreader with a spreader hinge and a clip applicator to position the clip occluder with respect to the left atrial appendage. The clip applicator can include a clip actuator to control a distance between the upper clip jaw and the lower clip jaw. The clip applicator can be removably coupled to the clip occluder with a retention suture. The ring occluder or clip occluder can include pharmacological and / or biological agents, such as anti-inflammatory and / or anti-arrhythmic agents and drugs. The occluder member can include a fabric covering."

Problems solved by technology

Embolic stroke is also a major cause of disability.

Although somewhat effective, there are numerous side effects, including bleeding and lifestyle compromises.

Pharmacological therapies (such as Warfarin®) are not well tolerated by patients.

The introduction of biomaterials into the left atrial appendage has resulted in the biomaterials eventually breaking down by resulting in clot formation.

However, any foreign device left in the chamber of the heart is a potential thrombosis-generating site.

In addition, biomaterials are known to eventually break down and result in clotting.

This is done under general anesthesia and may result in additional trauma to the patient.

While endoscopic or percutaneous approaches reduce the invasiveness of the surgical procedure, the above-described approaches have inherent limitations.

Surgical removal of the left atrial appendage is very invasive and often results in loss of atrial hormones, such as atrial natriuretic peptide (ANP), and significant bleeding.

Images